These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29655021)

  • 21. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
    Kishton RJ; Sukumar M; Restifo NP
    Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.
    Ye J; Ma C; Hsueh EC; Dou J; Mo W; Liu S; Han B; Huang Y; Zhang Y; Varvares MA; Hoft DF; Peng G
    EMBO Mol Med; 2014 Oct; 6(10):1294-311. PubMed ID: 25231413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting galectins in T cell-based immunotherapy within tumor microenvironment.
    Jin QY; Li YS; Qiao XH; Yang JW; Guo XL
    Life Sci; 2021 Jul; 277():119426. PubMed ID: 33785342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
    Yan L; Tan Y; Chen G; Fan J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating T cell metabolism in cancer immunotherapy.
    Dugnani E; Pasquale V; Bordignon C; Canu A; Piemonti L; Monti P
    Cancer Lett; 2017 Dec; 411():12-18. PubMed ID: 28974448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
    Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
    Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of T-cell inhibition: implications for cancer immunotherapy.
    Mittendorf EA; Sharma P
    Expert Rev Vaccines; 2010 Jan; 9(1):89-105. PubMed ID: 20021308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antitumour Weapons of the Immune System].
    Hořejší V
    Klin Onkol; 2015; 28 Suppl 4():4S15-22. PubMed ID: 26647884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of antioxidants in modulating anti-tumor T cell immune resposne.
    Oberholtzer N; Mills S; Mehta S; Chakraborty P; Mehrotra S
    Adv Cancer Res; 2024; 162():99-124. PubMed ID: 39069371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms.
    Davoodzadeh Gholami M; Kardar GA; Saeedi Y; Heydari S; Garssen J; Falak R
    Cell Immunol; 2017 Dec; 322():1-14. PubMed ID: 29079339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies.
    Waibl Polania J; Lerner EC; Wilkinson DS; Hoyt-Miggelbrink A; Fecci PE
    Front Immunol; 2021; 12():777073. PubMed ID: 34868044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cells and cancer - why do the killers become exhausted?
    Brück O; Keränen M; Dufva O; Kreutzman A; Mustjoki S
    Duodecim; 2016; 132(21):1984-92. PubMed ID: 29190050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity-Associated Myeloid Immunosuppressive Cells, Key Players in Cancer Risk and Response to Immunotherapy.
    Sanchez-Pino MD; Gilmore LA; Ochoa AC; Brown JC
    Obesity (Silver Spring); 2021 Jun; 29(6):944-953. PubMed ID: 33616242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart CARs engineered for cancer immunotherapy.
    Priceman SJ; Forman SJ; Brown CE
    Curr Opin Oncol; 2015 Nov; 27(6):466-74. PubMed ID: 26352543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune effects of targeted radiation therapy for cancer.
    Sridharan V; Schoenfeld JD
    Discov Med; 2015 Mar; 19(104):219-28. PubMed ID: 25828526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting tumor-associated acidity in cancer immunotherapy.
    Lacroix R; Rozeman EA; Kreutz M; Renner K; Blank CU
    Cancer Immunol Immunother; 2018 Sep; 67(9):1331-1348. PubMed ID: 29974196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response.
    Garris CS; Luke JJ
    Clin Cancer Res; 2020 Aug; 26(15):3901-3907. PubMed ID: 32332013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy.
    Kumar A; Chamoto K; Chowdhury PS; Honjo T
    Elife; 2020 Mar; 9():. PubMed ID: 32122466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity as an immune-modifying factor in cancer immunotherapy.
    Canter RJ; Le CT; Beerthuijzen JMT; Murphy WJ
    J Leukoc Biol; 2018 Sep; 104(3):487-497. PubMed ID: 29762866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.